ASTRAZENECA PLC |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,293 GBX | -0.62% |
|
+1.52% | +16.06% |
| 01:42pm | Pfizer, AstraZeneca, Morgan Stanley Pledge Investments, Jobs to France | MT |
| 11:55am | France Secures Billions at Foreign Investment Summit | DJ |
ETFs positioned on AstraZeneca PLC
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.38% | 1,166 M€ | +0.26% | ||
| 0.38% | 607 M€ | +0.05% | ||
| 0.37% | 25 M€ | +4.09% | - | |
| 0.28% | 391 M€ | +8.65% | - | |
| 0.27% | 0 M€ | 0.00% | - | |
| 0.25% | 36 M€ | +3.05% | - | |
| 0.25% | 34 M€ | +8.24% | - | |
| 0.21% | 242 M€ | +8.78% | ||
| 0.18% | 306 M€ | +5.84% | - | |
| 0.18% | 39 M€ | +5.63% | - | |
| 0.17% | 20 M€ | +1.30% | - | |
| 0.17% | 7 M€ | +0.11% | - | |
| 0.14% | 17 M€ | +2.80% | - | |
| 0.14% | 105 M€ | +3.42% | - | |
| 0.13% | 253 M€ | +8.06% | ||
| 0.09% | 34 M€ | +3.63% | - | |
| 0.08% | 234 M€ | +2.72% | - | |
| 0.07% | 8 M€ | +0.50% | - | |
| 0.07% | 54 M€ | +0.41% | - | |
| 0.00% | 1 M€ | 0.00% | - | |
| 0.00% | 29 M€ | -2.25% | - | |
| 0.01% | 146 M€ | -2.58% | - | |
| 0.01% | 25 M€ | -3.22% | - |
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:
- product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);
- collaboration revenue (4.4%).
Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
154.8
USD
Average target price
166.8
USD
Spread / Average Target
+7.72%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +16.06% | 240B | |
| +30.38% | 684B | |
| +29.62% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +9.27% | 208B | |
| -7.20% | 200B | |
| +7.68% | 166B | |
| -2.71% | 159B |
- Stock Market
- Equities
- AZN Stock
- Funds and ETFs AstraZeneca PLC